Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients

Background: Pathological complete response (pCR) to neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC) is still ascribed to a minority of patients. A pathway based-approach could highlight the predictive role of germline single nucleotide polymorphisms (SNPs). The primary a...

Full description

Bibliographic Details
Main Authors: Dreussi, Eva, Cecchin, Erika, Polesel, Jerry, Canzonieri, Vincenzo, Agostini, Marco, Boso, Caterina, Belluco, Claudio, Buonadonna, Angela, Lonardi, Sara, Bergamo, Francesca, Gagno, Sara, De Mattia, Elena, Pucciarelli, Salvatore, De Paoli, Antonino, Toffoli, Giuseppe
Format: Online
Language:English
Published: MDPI 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037760/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037760/

Similar Items